Enovis to Host Third Quarter 2022 Conference Call on November 2nd
Enovis Corporation (NYSE: ENOV) will host an investor conference call and live webcast on November 2, 2022, at 8:00 AM ET to discuss its Q3 2022 financial results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Enovis Corporation (NYSE: ENOV) will host an investor conference call and live webcast on November 2, 2022, at 8:00 AM ET to discuss its Q3 2022 financial results. An earnings press release will precede the call. Investors can access the live webcast through the Enovis website, and for participation, U.S. callers can dial (800) 715-9871, while international callers should use (646) 307-1963 with conference ID 1914045. A replay will also be available later on the website. Enovis focuses on innovative medical solutions for improved patient outcomes.
Details
News Market Reaction – ENOV
The recorded move for ENOV in the trading session of this news was +2.80%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Wilmington, DE, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its third quarter 2022 financial results on Wednesday, November 2, 2022 at 8:00AM ET and issue an earnings press release earlier that morning. A presentation related to the call will be available on www.enovis.com in the “Investors” section.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (800) 715-9871 (U.S. callers) and (646) 307-1963 (International callers) and provide the conference ID 1914045. A link to a replay of the call will also be available on the Enovis website later that day.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-421-1971
investorrelations@enovis.com
Source: Enovis Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.